Nuplazid

60 seconds with Daniel Cannone, D.O., United Church Homes

60 seconds with Daniel Cannone, D.O., United Church Homes

Q: The United Church Homes has reduced antipsychotic medications dramatically since 2012. How did you accomplish that?

FDA approves Parkinson's drug

The U.S. Food and Drug Administration approved Nuplazid (pimavanserin) tablets last week as the first approved drug to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease.